About Diceros Therapeutics
Diceros Therapeutics is a private company based in Newton, Massachusetts, incorporated in 2022 in Delaware. It has reported $12,609,962 raised in one offering on Form D since September 2022. Its chief executive is Stephen Seiler.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 19, 2022 | Sep 30, 2022amended Aug 5, 2024 | $12,609,962of $18.0M target | 13 | $969K | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Diceros Therapeutics's Form D filed Aug 5, 2024.
SS
Stephen Seiler
President & CEO, director
IW
Ids van der Weij
Director
WG
Wyatt Gotbetter
Director
Jonathan Fleming
Director
Also an executive officer and director at Aquacultural Research, a director at EnClear Therapies and a board of directors at Quiver Bioscience.